Anna Godi

477 total citations
22 papers, 347 citations indexed

About

Anna Godi is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Anna Godi has authored 22 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Anna Godi's work include Cervical Cancer and HPV Research (21 papers), Hepatitis B Virus Studies (14 papers) and Immunotherapy and Immune Responses (6 papers). Anna Godi is often cited by papers focused on Cervical Cancer and HPV Research (21 papers), Hepatitis B Virus Studies (14 papers) and Immunotherapy and Immune Responses (6 papers). Anna Godi collaborates with scholars based in United Kingdom, Italy and France. Anna Godi's co-authors include Simon Beddows, Sara L. Bissett, Luigi Marongiu, Elizabeth Miller, Clementina Cocuzza, John Parry, Trevor J. Wear, Roberto Ballardini, Luca Prodi and Christopher P. Moore and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Virology.

In The Last Decade

Anna Godi

22 papers receiving 342 citations

Peers

Countries citing papers authored by Anna Godi

Since Specialization

Citations

This map shows the geographic impact of Anna Godi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Godi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Godi more than expected).

Fields of papers citing papers by Anna Godi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Godi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Godi. The network helps show where Anna Godi may publish in the future.

Co-authorship network of co-authors of Anna Godi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Godi. A scholar is included among the top collaborators of Anna Godi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Godi. Anna Godi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection 2024 ·Nature Communications ·Gathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, John Schussler, Anna Godi, Rolando Herrero, Carolina Porras, Lisa Mirabello, John T. Schiller, Mónica S. Sierra, (unknown), Gary M. Clifford, Simon Beddows	2
2	Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay 2022 ·MethodsX ·Kavita Panwar, Anna Godi, Clementina Cocuzza, Nick Andrews, Jo Southern, Paul Turner, Elizabeth Miller, Simon Beddows	2
3	Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine 2022 ·Vaccine ·Kavita Panwar, Anna Godi, Clementina Cocuzza, Nick Andrews, Jo Southern, Paul Turner, Elizabeth Miller, Simon Beddows	9
4	Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies 2022 ·Microbiology Spectrum ·Anna Godi, (unknown), Clementina Cocuzza, Elizabeth Miller, Simon Beddows	2
5	Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes 2020 ·Journal of Virology ·Anna Godi, (unknown), (unknown), Kavita Panwar, Maxime Fleury, Shaowei Li, Qinjian Zhao, Ningshao Xia, Neil D. Christensen, Simon Beddows	6
6	Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine 2019 ·Vaccine ·Anna Godi, Kavita Panwar, (unknown), Clementina Cocuzza, Nick Andrews, Jo Southern, Paul Turner, Elizabeth Miller, Simon Beddows	29
7	Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies 2019 ·The Journal of Infectious Diseases ·Anna Godi, Troy J. Kemp, Lígia A. Pinto, Simon Beddows	14
8	Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies 2018 ·The Journal of Infectious Diseases ·Anna Godi, Marianna Martinelli, (unknown), Shaowei Li, Qinjian Zhao, Ningshao Xia, Clementina Cocuzza, Simon Beddows	9
9	Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance 2018 ·mSphere ·Karly S. Louie, (unknown), Caroline Reuter, Sara L. Bissett, Michelle Kleeman, Lesley Ashdown-Barr, (unknown), Anna Godi, Peter Sasieni, Simon Beddows	7
10	Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis 2017 ·Vaccine ·Sara L. Bissett, Anna Godi, Mark Jit, Simon Beddows	20
11	The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies 2016 ·Scientific Reports ·Sara L. Bissett, Anna Godi, Simon Beddows	20
12	Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine 2015 ·PLoS ONE ·Anna Godi, Sara L. Bissett, Elizabeth Miller, Simon Beddows	18
13	Amino acid motifs in both the major and minor capsid proteins of HPV51 impact antigenicity and infectivity 2015 ·Journal of General Virology ·Anna Godi, Andrea Piana, (unknown), Sara L. Bissett, Clementina Cocuzza, Simon Beddows, Tiziana Dell’Anna	5
14	Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines 2015 ·Journal of Virology ·Anna Godi, (unknown), Sara L. Bissett, Clementina Cocuzza, Elizabeth Miller, Simon Beddows	12
15	Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype 2015 ·Journal of Virology ·Sara L. Bissett, Anna Godi, Maxime Fleury, Antoine Touzé, Clementina Cocuzza, Simon Beddows	12
16	Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities 2014 ·Vaccine ·Sara L. Bissett, Eve Draper, Richard Myers, Anna Godi, Simon Beddows	22
17	Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage 2014 ·Infection Genetics and Evolution ·Luigi Marongiu, Anna Godi, John V. Parry, Simon Beddows	13
18	Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage 2014 ·BMC Cancer ·Luigi Marongiu, Anna Godi, John Parry, Simon Beddows	42
19	Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins 2014 ·Vaccine ·Sara L. Bissett, Giada Mattiuzzo, Eve Draper, Anna Godi, Dianna E. Wilkinson, Philip D. Minor, Mark Page, Simon Beddows	13
20	Catenated Cyclodextrins 1995 ·Chemistry - A European Journal ·Dominique Armspach, Peter R. Ashton, Roberto Ballardini, Vincenzo Balzani, Anna Godi, Christopher P. Moore, Luca Prodi, Nicholas D. Spencer, J. Fraser Stoddart, Malcolm S. Tolley, Trevor J. Wear, David J. Williams	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact